The affinity-purified protein (Fig. 1A, lane 3) was then digested in gel with trypsin (Promega) and analyzed by liquid chromatography-mass spectrometry (data not shown). Two peptides (VIQVIEDGDEVQIR and VLEDDYITIR) were detected, which confirmed that the protein was TcdC. The purified TcdC was used to raise anti-TcdC antibodies in a rabbit. Two hundred fifty micrograms of TcdC was mixed with the adjuvant Titermax (Sigma) and injected subcutaneously into rabbits. After two booster injections, anti-TcdC antibodies were collected and preadsorbed against crude cell extracts of E. coli strain BL21(DE3) harboring pET22b (without tcdC).
Specificity of TcdC antibody. The anti-TcdC antibodies were used to develop Western blots of proteins from cell extracts of C. difficile strains VPI 10463 and VPI 11186 and E. coli strains with or without tcdC (Fig. 1C) . The anti-TcdC antibody reacted with a single protein band of similar molecular weight in the extracts of E. coli and C. difficile cells expressing TcdC but not with proteins from E. coli or C. difficile cells which do not express TcdC.
Subcellular localization of TcdC in C. difficile cells. To determine the subcellular location of TcdC, we separated the cell proteins from C. difficile strain VPI 10463 into cytosolic and membrane fractions and probed these fractions for TcdC by Western blotting. Briefly, the cells were harvested by centrifugation, resuspended in Tris buffer (0.05 M Tris-HCl, pH 7.5) containing a protease inhibitor cocktail (Sigma), and disrupted by passage through a French pressure cell (no. 43398; Aminco) at 1,000 Kg/cm 2 . After being incubated with a mixture of DNase and RNase (50 g each) (100 g/ml) for 30 min, the cell lysates were centrifuged at low speed (4,000 ϫ g) for 15 min at 4°C to remove unbroken cells. The supernatant was centrifuged at 200,000 ϫ g for 60 min at 4°C to separate the cytosolic proteins (supernatant) from the membrane and peptidoglycan-associated proteins (pellet). The pellet was processed by two different methods. For the first, we separated the cytoplasmic membrane proteins from those associated with the peptidoglycan according to the method of Candela and Fouet (4) . This process involved resuspending the pellet in Tris-HCl (pH 7.4)-5 mM EDTA with 2% Triton X-100 for 30 min at room temperature to solubilize the membrane proteins, followed by centrifugation (20, 000 ϫ g for 1 h at 4°C) to pellet the peptidoglycan and its associated proteins. In the second http://jb.asm.org/ method, the pellet was resuspended in Tris-HCl (pH 7.4) with 10% sucrose, loaded onto a step gradient consisting of 2 ml of 15, 30, 40, 50, and 60% sucrose in the same buffer, and centrifuged at 200,000 ϫ g overnight before 0.5-ml fractions were collected for further analysis (8) . Equal amounts of Triton X-100-soluble and -insoluble membranes and cytosolic proteins (30 g) from isolated fractions were separated on an SDS-PAGE gel and analyzed by probing Western blots with anti-TcdC and rabbit antibodies raised against the streptococcal ribosomal proteins L7 and L12 (10). It has previously been shown that anti-L7/L12 antibodies cross-react with ribosomal proteins from a variety of bacteria (10) . The anti-TcdC antibody reacted against a protein band in both the Triton X-100-soluble and -insoluble membrane fractions but not against proteins in the cytosolic fraction (Fig. 2B) . As expected, the anti-L7/L12 antibodies detected a protein band in the cytoplasmic fraction. However, a weak reaction of anti-L7/L12 against the Triton X-100-insoluble membrane fraction (Fig. 2C ) was detected. This may be due to a small contamination of the membrane fraction with polysomes resulting from the centrifugation steps. While anti-TcdC serum detected a protein fraction in both the soluble and insoluble membrane factions, the majority of TcdC was found in the Triton X-100-soluble fraction, suggesting that TcdC is associated with the cytoplasmic membrane. Fractions collected after sucrose gradient centrifugation were separated by SDS-PAGE, transferred onto polyvinylidene difluoride membranes, and probed with two different antibodies: anti-TcdC and the anti-ATPase E. coli ␤ subunit (6). The anti-ATPase antibodies reacted with a C. difficile protein in fractions 16 to 19, and the anti-TcdC antibodies reacted with a protein in fractions 11 to 20. Hence, both ATPase (a cytoplasmic membrane protein) and TcdC in higher abundance were found in the same sucrose fractions (Fig. 3, lanes  16 to 19) , indicating that TcdC is associated with the cytoplasmic membrane. Note that bioinformatic software TMPRED (http://www.ch.embnet.org/software/TMPRED_form.html) has predicted a putative transmembrane domain in the Nterminal region of TcdC (amino acids 31 to 51).
Expression analysis of TcdC in C. difficile cells. Cells from a growing culture of VPI 10463 were harvested at different time points, and the relative amount of TcdC per cell (i.e., optical density at 550 nm [OD 550 ]) at each time point was determined by Western blotting. Maximum levels of TcdC were found during the exponential phase of growth, and levels decreased as the culture approached stationary phase (Fig. 4) . That equal numbers of cells were employed in this analysis is shown by the equal levels of ATPase detected in the samples. Hundsberger et al. (9) have demonstrated a similar pattern for the transcription of tcdC, which is at maximum levels during exponential growth and decreases as the cells go into stationary phase. Hence, the amounts of TcdC per cell during the exponential and stationary phases of growth mimic the transcriptional activity of the TcdC gene.
In summary, we have cloned and expressed TcdC in E. coli cells and raised polyclonal antibodies against this protein. These antibodies were used to demonstrate that TcdC is membrane associated and to characterize its expression during growth in culture. Recently, there have been several reports concerning increases in the rate and severity of CDAD that may be associated with the emergence of a highly toxic, antibiotic-resistant strain of C. difficile (12, 15, 20) . The predominant strain in these outbreaks has become resistant to fluoroquinolones, carries the binary toxin genes, and has a partial (18-bp) deletion in tcdC. Although the importance of the binary toxin and the 18-bp deletion to the virulence of C. difficle is unknown, the finding that the prevalence of these factors is much higher in isolates from outbreaks associated with increased morbidity suggests that they may affect the severity of CDAD.
Three different mutant alleles of tcdC have been identified thus far, and it has been suggested that these tcdC variants may have influenced the increased elaboration of toxins A and B in these strains (16, 20) . For example, C. difficile strain 8864 carries a mutation resulting in a truncated TcdC protein (22 amino acids), which has been postulated to contribute to the extreme cytotoxicity of this strain (17) . In a different study involving comparative analysis of pathogenicity loci in clinical isolates, two variant tcdC genes were identified: one variant codes for a truncated TcdC protein of only 61 amino acids, and the other carries an 18-bp deletion (18) . Both variants produce increased amounts of toxins A and B. Finally, the 18-bp deletion in tcdC that has been found in C. difficile strains isolated from recent outbreaks in the United States and Canada (toxin type III) produced 16-fold more toxin A and 23-fold more toxin B than the control strains isolated from the same geographical regions at the same time (toxin type 0) (20) . Although it is not known whether these mutant alleles render their tcdC products nonfunctional, the increased toxin production associated with tcdC deletions has led to the speculation that TcdC acts as a negative regulatory protein with respect to toxin expression. Localization of transcription factors to membranes would appear to be incompatible with the control of gene expression. However, similar membrane-associated transcriptional regulators have been reported for other bacteria. Some examples are ToxR of Vibrio cholerae (11) and the RpoE sigma factor of E. coli (5) . Only with further genetic and physiological studies of TcdC will we begin to understand its role in the regulation of the expression of the toxin genes of this very important pathogen. Our finding that TcdC resides in the C. difficile membrane may have important implications for such studies. 
